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We have described multipotent progenitor-like cells within the
major pancreatic ducts (MPDs) of the human pancreas. They ex-
press PDX1, its surrogate surface marker P2RY1, and the bone
morphogenetic protein (BMP) receptor 1A (BMPR1A)/activin-like ki-
nase 3 (ALK3), but not carbonic anhydrase II (CAII). Here we report
the single-cell RNA sequencing (scRNA-seq) of ALK3bright+-sorted
ductal cells, a fraction that harbors BMP-responsive progenitor-like
cells. Our analysis unveiled the existence of multiple subpopulations
along two major axes, one that encompasses a gradient of ductal
cell differentiation stages, and another featuring cells with transi-
tional phenotypes toward acinar tissue. A third potential ducto-
endocrine axis is revealed upon integration of the ALK3bright+ dataset
with a single-cell whole-pancreas transcriptome. When transplanted
into immunodeficient mice, P2RY1+/ALK3bright+ populations (enriched
in PDX1+/ALK3+/CAII− cells) differentiate into all pancreatic lineages,
including functional β-cells. This process is accelerated when hosts are
treated systemically with an ALK3 agonist. We found PDX1+/ALK3+/
CAII− progenitor-like cells in the MPDs of types 1 and 2 diabetes
donors, regardless of the duration of the disease. Our findings open
the door to the pharmacological activation of progenitor cells in situ.
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The existence of progenitor-like cells in the human pancreaticduct tree, despite conflicting findings in mice (1, 2), is sup-
ported by experimental evidence (reviewed in ref. 3). We have
recently characterized one such cell population in human major
pancreatic ducts (MPDs) and pancreatic duct glands (PDGs) (4,
5). These cells express the ductal/β-cell marker pancreatic and
duodenal homeobox-1 gene (PDX1) and the bone morphoge-
netic protein (BMP) receptor 1A (BMPR1A), also known as
activin-like kinase-3 (ALK3). Antibodies against ALK3 and the
purinergic receptor P2Y1 (P2RY1), which we have established
as a surrogate surface marker for PDX1 (4), can be used to sort
live progenitor-like cells that expand in vitro in the presence of
BMP-7 and differentiate along all three adult pancreatic lineages
(endocrine, acinar, and ductal) upon removal of this factor (4).
This marker combination (P2RY1+/ALK3bright+) specifically
excludes islets, which are ALK3− (4). Another salient feature of
these cells is that, notwithstanding their location in the MPD
epithelium, they lack protein expression of carbonic anhydrase II
(CAII), a marker previously thought to be pan-ductal (6). Thus,
PDX1+/ALK3+/CAII− cells, which we hypothesized to be pro-
genitors, are readily detected in human MPDs and PDGs, often
intercalated with regular ductal PDX1+/ALK3+/CAII+ cells (4).
In this report, we conducted single-cell RNA-sequencing
(scRNA-seq) analysis of sorted human pancreatic ALK3bright+
cells, which offers a “high-magnification” view of all of the cell
types within the ductal tree. This analysis shows the existence of
multiple ductal subpopulations that run the gamut from mature
functional ductal cells to undifferentiated/transitional cells, including
progenitor-like cells with a transcriptional profile consistent with
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stress-induced de-differentiation. P2RY1+/ALK3bright+ sorting
enriches in CAII− cells from such progenitor-like clusters. We
demonstrate that sorted P2RY1+/ALK3bright+ cells engraft in
immunocompromised mice, where they spontaneously mature
into multiple pancreatic endocrine and exocrine cell types. This
process was accelerated by the systemic administration of THR-
123, a cyclic peptide with ALK3 agonism activity. Next, we
sought to explore whether PDX1+/ALK3+/CAII− existed in
samples from donors with type 1 and 2 diabetes (T1D/T2D). We
confirm that progenitor-like cells exist in the MPD/PDG epi-
thelium of all patients examined, regardless of the duration of
the disease. Our findings that human P2RY1+/ALK3bright+ cells
can be pharmacologically stimulated in vivo, combined with the
observation that similar cells may be intact in T1D/T2D patients,
have potential therapeutic implications.
Results
scRNA-Seq Analysis of ALK3+ Cells Reveals Ductal Heterogeneity and
Suggests Transitional Phenotypes. We have previously determined
that the P2RY1+/ALK3bright+ fraction of the human exocrine
pancreas is enriched in PDX1+/ALK3+/CAII− progenitor-like
cells that can be cultured in defined conditions, expand in the
presence of BMP-7, and exhibit multipotency when BMP-7 is
removed. To further analyze in depth the composition of the
human ALK3+ ductal compartment, we conducted scRNA-seq
of sorted ALK3bright+ cells from human nonendocrine pancreatic
tissue obtained after islet isolations at the Diabetes Research
Institute (two donors) and the University of Pittsburgh (one
donor) (SI Appendix, Fig. S1 A–E and Table S1). Our rationale
was that, by analyzing the ALK3bright+ population at large, we
would be able to study the PDX1(P2RY1)+/ALK3+ cells (a
subpopulation thereof) in their broader context within the ductal
tree. Fig. 1A presents a scheme of the experimental plan. The
expected outcome of this sorting strategy is the selection of ep-
ithelial cells from the MPDs and PDGs with the exclusion of a
significant percentage of ALK3dim+ cells (likely from small
ducts), as determined in Qadir et al. (4). We also depleted
contaminating mesenchymal cells by CD90− selection, further
enriching in epithelial cells.
Approximately 2,000 cells per preparation were sequenced at
250,000 reads per cell (Genewiz). Only single cells with mito-
chondrial RNA less than 20% of total RNA were included (SI
Appendix, Fig. S1H). Using principal component analysis and
clustering with the R v.3.5.3 package Seurat 3.1.1 (SI Appendix),
an uniform manifold approximation and projection (UMAP)
plot of the combined three preparations (4,878 cells) was gen-
erated (Fig. 1B and SI Appendix, Fig. S1 F–L). UMAP is a novel
nonlinear dimensionality reduction algorithm for the analysis of
high-dimensional data (7), which has proven superior to
t-distributed stochastic neighborhood embedding for resolving
subtle differences in cell populations (8–11). A scatterplot of
differentially expressed (DE) genes and a heatmap with the top
20 DE genes/cluster (vs. all of the other clusters) are presented
in SI Appendix, Fig. S1I and Fig. 1C, respectively. Clustree v0.4.1
(12) was used to choose the highest clustering resolution without
cluster destabilization or mixing (SI Appendix, Fig. S1J). SI Ap-
pendix, Fig. S1 K and L present the individual contribution of
each donor to the combined dataset. The overall epithelial/
ductal identity of the sorted cells was confirmed by the wide-
spread expression of the ductal markers KRT19 and SOX9, the
epithelial marker CDH1, and the absence of any meaningful
expression of the archetypal acinar marker AMY2B and the en-
docrine markers ISL1, insulin (INS), glucagon (GCG), somato-
statin (SST), and PPY (Fig. 1D).
The only exception was the smaller cluster 7, which was largely
KRT19− and SOX9−. The analysis of DE genes and gene on-
tology (GO)-term pathways (Fig. 2 A–D and Datasets S1 and S2)
suggests an immune cell identity. BMP signaling regulates
proliferation/differentiation in the immune system (13), and
ALK2/ALK3 are functional BMP receptors in macrophages.
Therefore, it is likely that ALK3+ sorting resulted in the carry-
over of this small immune-related subpopulation.
Fig. 2A shows the predicted identity of each cluster according
to the above analysis. Representative top DE genes and GO
pathways are indicated in Fig. 2D and SI Appendix, Fig. S2B, as
well as Datasets S1 and S2. For identification purposes, we se-
lected those whose expression is most specific to any given
cluster vs. the rest. We detected two major groups of cells:
Productal (clusters 1 to 4 in Fig. 2 D, Lower) and ducto-acinar
(clusters 5 to 6 in Fig. 2 D, Upper). The distinction between
ducto-acinar and productal is based on the DE of numerous
acinar genes in clusters 5 to 6 (Fig. 2E and SI Appendix, Fig. S2A)
Cluster 1 is represented by osteopontin/secreted phospho-
protein 1 (SPP1). This gene was previously identified as a marker
of undifferentiated pancreatic progenitors in mice (14), and also
by scRNA-seq in the developing mouse pancreas as a marker of
“proliferative ducts” (15). Cluster 1 also has the highest PDX1
and inhibition of differentiation (ID)-1, -2, and -4 expression in
the entire dataset (SI Appendix, Fig. S2 C and D). High expres-
sion of ID1-4 is typical of progenitors, where they sequester basic
helix–loop–helix transcription factors, leading to the inhibition of
lineage-specific and cell cycle-inhibitory genes (16). ID2, in
particular, has been shown to regulate BMP-dependent pan-
creatic progenitor expansion in mice (17). Elevated ID expres-
sion was also a hallmark of the P2RY1+/ALK3bright+ cells
previously described by our team as progenitor-like, especially
after the addition of BMP-7 (4). In line with the hypothesis that
cluster 1 may harbor the multipotent progenitors therein de-
scribed, among the most DE genes we also found HES1, FOS,
and JUN (Datasets S1 and S2). HES1 is an inhibitor of differ-
entiation up-regulated by Notch signaling, which is associated
with progenitor proliferation during pancreatic development
(18). FOS and JUN are the two components of the activator
protein 1 early response transcription factor, which is essential
for the proliferation of ductal epithelial cells in the context of
pancreatic cancer. While there is no evidence that the donors
used in this study had any malignancy, we conducted a search for
DE pancreatic cancer pathways (19) to rule out any such con-
ditions, which may have confounded the interpretation of our
data. This search was negative, further reinforcing the notion
that this cluster may harbor progenitor cells instead. In fact, also
among the top DE genes in this cluster is TFPI2, a pancreatic
tumor suppressor (20).
Inflammation/stress responses were also recurrent themes
from the DE and GO pathway analyses conducted for cluster 1.
In fact, C-reactive protein (CRP) was the top DE gene. The most
likely source of stress in the ducts is protease secretion. Several
serpins [a superfamily of proteins that protect exocrine cells
against their own secreted proteases (21)] are indeed among the
top DE genes in this cluster (Datasets S1 and S2). Therefore, the
above progenitor-like signature is also consistent with potential
de-differentiation processes associated with stress. Although our
data do not offer direct confirmation of this hypothesis, stress-
mediated de-differentiation has been extensively reported in the
ductal tree (reviewed in ref. 3).
To validate gene-expression findings, we examined the
immunostaining of select DE expressed markers for each cluster
in the Human Protein Atlas, a comprehensive resource of more
than 24,000 antibodies and 13 million immunohistochemistry
images (22, 23). Since differential expression is not exclusive
expression, we often found that markers with a positive signal
were not restricted to specific pancreatic compartments. Due to
this, we focused on the regions that exhibited the most defined
staining for any given DE gene. For some of the top DE genes in
cluster 1 (FOS, TSPAN8, SPP1) (Datasets S1 and S2), a strong
signal was commonly observed within larger ductal structures





























containing a fibromuscular wall and in connection with PDGs (SI
Appendix, Fig. S3). The presence of Mucin 20 among the DE
genes further confirms the potential link of these cells to PDGs,
which have long been proposed to be niches of pancreatic
progenitors (24–27).
DE GO pathways in cluster 2 (trefoil factor 1, TFF1+) reflect
active extracellular matrix remodeling, as evidenced by the
presence of multiple metalloproteinases (MMP1, MMP7,
MMP10) among the top DE genes. This list is headed by TFF1,
with TFF2 close behind. The concerted action of these two genes
mediates the migration of cells out of PDGs following in-
flammatory injury (26). Epithelial cell migration, alongside ex-
tracellular matrix remodeling are, in fact, the top GO pathways
differentially up-regulated for this cluster. Another interesting
DE gene is c19orf33, which encodes the hepatocyte growth factor
activator inhibitor type 2-related small peptide (H2RSP). This
protein is expressed in the epithelium of the gastrointestinal
tract, where it is up-regulated in response to injury. The nuclear
translocation of H2RSP has been suggested to have a role in the
transition from proliferation to differentiation (28). Progenitor
markers PDX1, and ID1-4 are also relatively elevated (SI Ap-
pendix, Fig. S2C). HMGA1 [a transcription factor that mediates
motility and has been associated with pancreatic adenocarci-
noma invasiveness (29, 30)] and S100A6 [calcium-binding pro-
tein also associated with pancreatic cancer cell motility (31)] are
two other DE genes in this cluster that further suggest a mi-
gratory phenotype. As before, a search for DE pancreatic cancer
pathways (19) was negative. Immunostaining for these markers
shows that the cells with the strongest signal are either in major
ductal/PDG structures or seemingly delaminating from them (SI
Appendix, Fig. S3). Single cells positive for these markers can be
detected throughout the parenchyma, including acini and islets.
Cluster 3 (AKAP12+) exhibits the DE of multiple cytokeratins
(KRT17, KRT81, KRT23, KRT7, KRTAP2-3), which are markers
of epithelial differentiation (32). GO analysis shows the differ-
ential elevation of homotypic cell–cell adhesion, positive regu-
lation of cell differentiation, and negative regulation of growth
pathways. Taken together, these features suggest terminally
differentiated ducts. Immunostaining of some of the top DE
genes (KRT17, KRT23, ANXA1, ANXA3, LAMA3) (SI Appendix,
Fig. S4) confirms widespread staining in small ducts, with larger
ones sometimes displaying intermittent signal patterns.
GO pathway analysis of cluster 4 (WSB1+) reveals cells with
an active transcriptional profile and the up-regulation of path-
ways, such as negative regulation of differentiation, Notch, and
Wnt signaling. Interestingly, the immunostaining of some of the
top DE genes for this cluster suggests a centroacinar location (SI
Appendix, Fig. S4B). Centroacinar cells are difficult to study
because of the lack of markers to distinguish them from the
adjacent intercalated small ductal cells (33). Studies in mice and
zebrafish suggest that these cells express high levels of aldehyde
dehydrogenases (ALDH), which have been proposed as markers
for populations enriched in progenitors (34). However, this has
not been confirmed in humans, where centroacinar ALDH ac-
tivity has only been detected recently in children and during
pathological processes (35). We did not observe DE of ALDHs
in this cluster, and the Human Protein Atlas does not show
differential centroacinar expression of these markers. However,
ALK3bright+ sorting may have excluded many centroacinar cells,
as ALK3 expression is brightest in major ducts but tends to be
dimmer in smaller ducts (4). Therefore, it is possible that our
dataset comprises only a fraction of the overall centroacinar
population. Still, we base the hypothetical assignment of cen-
troacinar identity to this cluster on several observations. First, its
position at the crossroads between productal and ducto-acinar
Fig. 1. scRNA-seq identifies cellular heterogeneity
across human ALK3bright+ pancreatic ductal cells. (A)
Scheme of the experimental approach employed to
isolate ALK3bright+ cells and derive single-cell libraries
using the 10X Genomics microfluidics system. Data
generated from sequenced single-cell libraries are
analyzed to dissect cellular substructure. (B) UMAP
plots of ductal populations from individual donor
pancreas (n = 3, 4,878 cells). Each dot represents the
transcriptome of a single ALK3bright+ cell, with color
coding defining clusters of cells having similar tran-
scriptional identities. (C) Gene-expression heatmap
of the top 20 most DE genes in each cluster com-
pared to all other clusters. Genes are represented in
rows and cell clusters in columns. Select genes are
indicated to the left. (D) Single-cell gene expression
of known markers of ductal (KRT19 and SOX9), ep-
ithelial (CDH1), acinar (AMY2B), and endocrine (ISL1,
INS, GCG, SST, PPY) cells. Scale bars represent
z-test–normalized gene expression in C and gene
counts in D.






















Fig. 2. Identification of multiple subpopulations of ALK3bright+ ductal cells in the human pancreas. (A) UMAP plot mapping multiple subclusters across the
single-cell dataset (n = 3). Each cluster is defined by a specific color and a representative DE gene. The dotted line divides ducto-acinar or “transitional to
acinar” clusters (Upper) from “productal” clusters (Lower). (B) Gene-expression dot plot of select DE genes in each cluster. Rows depict clusters, while columns
depict genes. The intensity of any given point indicates average expression, while its size represents the proportion of cells expressing a particular gene.
Dotted regions identify select genes for a particular cluster. The scale bar represents average expression in gene counts. (C) UMAP expression plots of
representative DE genes for clusters 3 (small ducts; KRTAP2-3, AKAP12); 2 (activated/migrating progenitor cells; TFF1, IGFBP3); 1 (stress/harboring progenitor-
like cells; CRP, SPP1); 4 (centroacinar; WSB1, XIST); 5 (transitional to acinar 1; CEL, OLFM4); 6 (transitional to acinar 2; SYCN, CPA2); and 7 (immune cells; SRGN,
IDO1). (D) GO-driven pathway analysis of DE genes with a ≥twofold change across clusters 1 to 7. (E) Violin plots for the expression of acinar (Left) and ductal
genes (Right). Expression in each cell is shown along with the probability density of gene expression, denoted by the shape of the plot.





























axes is consistent with cell types known to be at the interface
between acinar and ductal tissues. Second, as indicated above,
the immunostaining profile of some DE markers (SI Appendix,
Fig. S4B), including epithelium-specific transcription factor-3
(ELF3), vacuole membrane protein-1 (VPMP1), or WD repeat
and SOCS box containing-1 (WSB1) suggests a centroacinar lo-
cation. Many studies suggest a direct involvement of centroacinar
cells in neoplastic transformation trough centroacinar-to-ductal
transdifferentiation (36). In this context, mutated forms of the
above DE markers ELF3 (37), VMP1 (38), and WSB1 (39) have
all been associated to neoplastic transformation of the pancreas.
Finally, Notch signaling, which has been characteristically associ-
ated to centroacinar cells (40), is one of the top DE pathways in
GO analysis. Taken together, the above evidence is consistent with
the hypothesis that cells from cluster 4 are centroacinar.
The ducto-acinar clusters (5, 6), while predominantly ductal in
nature (they are mostly negative for the archetypal acinar marker
AMY2B and positive for the ductal marker KRT19), also feature
the differential expression of acinar-specific genes, such as CEL,
REG3A, REG1A, or CPA1 for cluster 5 (OLFM4+) and CLPS,
CELA2A/3A/3B, or PGA5 for cluster 6 (CPA2+) (Fig. 2 B and E
and SI Appendix, Fig. S2A). The latter already shows up-
regulation of typical acinar cellular processes, such as zymogen
activation (41) and the metabolization of glutathione (42).
Immunostaining of most of these DE genes for clusters 5 and 6 is
widespread throughout the pancreas and difficult to pinpoint to
specific locations, since proteases are secreted by the acinar
tissue into the ducts. However, some of these makers exhibit a
distinct centroacinar position (SI Appendix, Fig. S4).
Taken together, our data suggest that the ALK3bright+-sorted
population harbors an assortment of ductal cell types, ranging
from cells with progenitor-like features to mature ducts, as well as
subpopulations that exhibit some acinar-like expression patterns.
Pseudotemporal Analysis Suggests Two Transitional Axes in the
ALK3bright+ Ductal Compartment. Given the indications of poten-
tial differentiation gradients between ductal and acinar cells in
clusters 4-5-6, as well as between different ductal cell types in
clusters 1-2-3, we used Monocle v2.10.1 to arrange the cells in an
unbiased pseudotemporal manner; that is, following a “de-
velopmental/transitional” path according to their transcriptomic
similarity. This strategy has been used to determine lineage dy-
namics during pancreatic development (43). The results of this
analysis after the bioinformatics removal of the immune cluster 7
are shown in Fig. 3 A and B. The top “ducto-acinar” arm of the
graphic in Fig. 3A indicates that there is a pseudotemporal
continuum, with a progressive acquisition of acinarity following
the sequence from clusters 4 (centroacinar) to 6 (transitional to
acinar 2). Such inference, while solely based on bioinformatics
tools, strongly suggests the existence of cells transitioning from
ductal to acinar phenotypes (4-5-6) or vice versa (6-5-4). Simi-
larly, the bottom “productal” arms are also arranged in a manner
that could be interpreted as progenitor cells (cluster 1) pro-
gressively becoming, upon activation and migration, cells of
cluster 2. These cells lie at the crossroads between two differ-
entiation paths: One toward centroacinar-acinar phenotypes (2-
4-5-6) and another toward differentiated ducts (2-3). The wide-
spread distribution of the cells of cluster 1 across the entirety of
the productal arms suggests that these cells may give rise to (or
result from the de-differentiation of) all mature ductal cell types.
The notion that adult ducts harbor progenitor cells has been
extensively studied, and the literature describes numerous
markers for such cells, both in mice and humans. Our analysis of
the ductal progenitor cell niche allowed us to map some of these
against the UMAP plot. As shown in Fig. 3C, several have a
widespread distribution (i.e., are found in both productal and
ducto-acinar axes). That is the case of CTNND1 (44) and CD24
(45). While the expression of SOX9 (27, 46) is weaker in clusters
4 and 5, it is robustly expressed in clusters that are in both the
productal axis (1–3) as well as in the proacinar cluster 6. Other
markers, such as CEACAM6 (47), Prominin-1/CD133 (48), and
F3/CD142 (49, 50), are detected preferentially in the productal
axis. Interestingly, GP2 (51, 52) is expressed almost exclusively in
the ducto-acinar axis (clusters 5 and 6), which is consistent with
the recent discovery that this gene marks progenitor-like de-
differentiated acinar cells (49). Taken together, our data con-
firm the existence of two major lineage differentiation axes in the
adult ALK3bright+ ductal compartment.
Alignment of the ALK3bright+ Dataset Against a Single-Cell Resolution
Transcriptome of the Whole Pancreas Confirms the Ducto-Acinar
Transitional Axis and Suggests an Association between Productal
and Endocrine Compartments. To ascertain the position of sorted
ALK3bright+ populations in the larger context of the pancreas, we
plotted our dataset against two other datasets previously repor-
ted for human islets (47, 53), which are known to contain re-
sidual amounts of ductal and acinar cells and therefore offer a
rudimentary atlas of most cell types in the organ (53–55). Fig. 4A
and SI Appendix, Fig. S5 present the combined UMAP plot,
cluster resolution, heatmap, and dot-plot of select DE genes of
the ALK3bright+ clusters vs. the whole-pancreas integrated
dataset, respectively. The cluster color coding of our original
dataset has been preserved in the integrated graphic. The fact
that the original clusters are largely maintained following the
integration with a whole-pancreas dataset further confirms their
distinctive identity. The only difference is that, upon integration,
former cluster 2 (activated/migrating progenitors) is split into
two subclusters, now identified by two different shades of green,
and cluster 4 (centroacinar cells) disappears. Representative
genes for each cluster are indicated in Fig. 4A (heatmap in SI
Appendix, Fig. S5B). The contribution of the ALK3bright+ dataset
(teal) is shown against the scRNAseq “map” of the whole pan-
creas (coral) in the circular inset of Fig. 4A. This analysis con-
firms that ALK3bright+ cells fall under any of the two categories
described above: Productal (bottom area in Fig. 4A) or ducto-
acinar (top right area in Fig. 4A). The latter appears to seam-
lessly merge with the population defined as “acinar” in the
whole-pancreas dataset. SI Appendix, Fig. S5C shows that the
whole-pancreas–derived acinar cells are more acinar than the
ALK3bright+-sorted “transitional to acinar” clusters (higher
CPA1/AMY2A and expression of AMY2B, which is undetectable
in the ALK3bright+ dataset). This, coupled with the expression of
KRT19 in those clusters, further confirms their transitional na-
ture. Importantly, no cells from the ALK3bright+ dataset corre-
spond to INS-expressing cells (i.e., all INS+ cells derive from the
whole-pancreas dataset) (SI Appendix, Fig. S5C).
The Monocle arrangement of the integrated dataset is depic-
ted in Fig. 4B. Comparing this to the ALK3bright+ dataset alone,
cells of cluster 2 (activated/migrating ductal progenitors) remain
at the crossroads between the productal axis (Fig. 4B, box I), the
ducto-acinar arm (Fig. 4B, box II) and what appears to be a
ducto-endocrine branch (Fig. 4B, box III). Box IV in Fig. 4B
indicates nonepithelial cells (mesenchymal, endothelial, im-
mune). This pseudotemporal arrangement suggests that the
differentiation axes previously identified within ALK3-sorted
ductal cells are not only conserved upon integration with the
whole-pancreas dataset, but may also span the endocrine com-
partment as well. This would be consistent with the observation
of a spatial continuity between ductal and β-cell clusters (56), as
well as with the historical evidence of ductal-to-endocrine β-cell
neogenesis (reviewed in ref. 3).
Fig. 4 C and D show additional pseudotemporal analyses fo-
cusing specifically on ductal+acinar cells (i.e., excluding endo-
crine and immune/mesenchymal clusters) and ductal+endocrine
cells (i.e., excluding acinar and immune/mesenchymal clusters).
The first (Fig. 4C) is similar to that previously shown in Fig. 3A






















for the sorted ALK3bright+ cells, which is not surprising, since
most cells derive from that dataset. The analysis of the ducta-
l+endocrine clusters (Fig. 4D) further supports the existence of
a differentiation gradient from progenitors (cluster 1, blue) to
activated/migrating progenitors (cluster 2, green), which then
bifurcates into GCG+ (top arm in Fig. 4D) and INS+ (bottom
arm in Fig. 4D) arms.
Regular UMAP plots are bidimensional reductions of multi-
dimensional data. While 2D renderings sometimes distort the
relative position of clusters, this was not the case in the in-
tegrated dataset, whose 3D analysis showed maintenance of the
previously determined spatial cluster distribution (Movie S1).
Sorted Human P2RY1+/ALK3bright+ Cells Exhibit Multilineage Differentiation
Potential In Vivo, and This Outcome Is Enhanced upon Systemic
Administration of a BMPR Agonist. We have previously shown that
sorted ALK3bright+/P2RY1+ cells exhibit a progenitor-like behavior
following exposure to BMP receptor agonists in vitro (4). The
replication of such outcomes in vivo may set the stage for therapies
aimed at pharmacologically restoring islet mass. In an attempt to
correlate our ALK3bright+ scRNA-seq findings and the previous
analyses on a subset of such cells (ALK3bright+/P2RY1+), we ob-
served that PDX1 (the marker for which P2RY1 is a surrogate) is
almost exclusively expressed in cluster 1 (Fig. 5 A, Left). We hy-
pothesized earlier that this cluster harbors progenitor-like cells,
characterized by high PDX1 and ID1-2 and -4 expression. Sorted
ALK3bright+/P2RY1+ cells are highly depleted of BMP-
7–unresponsive CAII+ cells (4) (SI Appendix, Fig. S6 A–F). In-
triguingly, cluster 1 had a significant number of CAII+ cells (Fig. 5 A,
Center). However, we found that a vast majority of the cells with high
PDX1 expression did not coexpress CAII (Fig. 5 A, Right). Taken
together, these observations suggest that 1) only a subset of cells from
cluster 1 is progenitor-like and 2) ALK3bright+/P2RY1+ sorting en-
riches for the progenitor-like cells (PDX1+/ALK3+/CAII—), which
are preferentially found within cluster 1.
Fig. 3. Ductal cells show transitional dynamism in pseudotime. (A) Monocle-generated plots presenting pseudotime ordering and differentiation trajectory
of cell clusters. Color coding is as shown in Fig. 2A. Clusters 4-5-6 are arranged in a manner that suggests ductal-acinar transition (bottom left arm), while
activated/migrating progenitor-like cells (cluster 2) are saddled between the productal and ducto-acinar clusters. (B) Monocle-generated plots showing
pseudotime-ordered expression of selected marker genes: TFF1 (cluster 2), SPP1 (cluster 1), CPA2 (cluster 6), and AKAP12 (cluster 3). The color of a cell shows
its cluster identity (as in Fig. 2A). Lines denote relative expression of each marker in pseudotime. (C) UMAP plots and corresponding violin plots showing
relative gene expression for markers previously associated with ductal progenitors. Each dot in the violin plots represents the expression of a single cell, while
the shape of the plot denotes probability density. Scale bars denote average expression in gene counts.





























Based on the above, we transplanted ALK3bright+/P2RY1+
cells to test the prediction that this subset of cells that maps in
the region of cluster 1 would act as progenitors in vivo. We
reasoned that this approach would be preferable to the alter-
native of transplanting cells sorted using yet-undefined surface
markers specific for this cluster (which may or may not yield
separation between CAII+ and CAII− cells). These experiments
were conceived as proof-of-principle that human progenitor-like
cells can differentiate into adult phenotypes in vivo, and not to
model any potential therapeutic intervention. Therefore, we only
transplanted subtherapeutic cell dosages in nondiabetic animals.
Transplantation of sorted P2RY1+/ALK3bright+ cells was done
under the kidney capsule of immunodeficient (nu/nu) mice.
These cells are hormone-negative (4) (Figs. 1D and 4A and SI
Appendix, Fig. S5C). The strategy is schematized in Fig. 5B. Five-
to 6-wk-old nu/nu mice received 5 × 105 P2RY1+/ALK3bright+
Fig. 4. Alignment of the ALK3bright+ clusters
against a scRNA-seq dataset of the whole
pancreas confirms the ducto-acinar transi-
tional axis and suggests potential association
of the productal and endocrine compart-
ments. (A) UMAP plot showing cellular dis-
tribution when the ALK3bright+ dataset (n = 3,
4,878 cells) is mapped against two combined
islet datasets claimed to represent the whole
pancreas (3,277 cells). Clustering of pancre-
atic subtypes reflects differential gene ex-
pression and was validated by visualizing
gene expression in UMAP plots (left side:
endocrine; top: endothelial, immune, mes-
enchymal and acinar; right side: ductal). Scale
bars for each marker denote average ex-
pression in gene counts. (Inset) UMAP plot
showing distribution of ALK3bright+ cells (teal
color) vs. the whole-pancreas dataset (coral
color). (B) Single-cell arrangement based on
pseudotime calculations of the integrated
whole-pancreas and ALK3bright+ datasets. Cell
ordering analysis results in four main arms: I
(productal), II (ducto-acinar), III (ducto-endocrine),
and IV (immune/mesenchymal). (C) Pseudotime-
ordered ductal and acinar components of the
integrated whole-pancreas and ALK3bright+ cell
datasets. (Inset) UMAP plot showing the distri-
bution of clusters based on cellular identity. (D)
Pseudotime-ordered ductal and endocrine
components of the integrated whole-pancreas
and ALK3bright+ cell datasets. (Inset) UMAP
plot showing the distribution of clusters based
on cellular identity.






















cells sorted from n = 3 donors in three independent experiments
(demographics in SI Appendix, Table S1). Six mice were trans-
planted in each of the three experiments. Males were used in
Exps. 1 and 3, whereas in Exp. 2 only females were used.
Although the primary endpoint was to test the hypothesis that
sorted progenitor-like cells spontaneously differentiate upon
transplantation, we also wanted to test whether the process could
be enhanced by treating the recipient animals with a BMP re-
ceptor agonist. Thus, half the mice in each experiment (three)
also received daily intraperitoneal injections (10 mg/kg of body
weight) of THR-123, a small cyclic peptide with ALK3 agonism
activity (5, 57). The treatment was for 10 d, starting 24 h after the
transplantation. The other three animals per experiment re-
ceived a similar regimen of saline injections.
Circulating human C-peptide (hC-pep) values were measured
in both groups at 2 and 4 wk after transplantation. As shown in
Fig. 5C, there was measurable hC-pep in all three experiments
at both time points, indirectly establishing the formation of
Fig. 5. Sorted P2RY1+/ALK3bright+ cells display multilineage differentiation potential upon transplantation in immunodeficient mice. (A) The ALK3bright+/
P2RY1+ fraction is enriched in PDX1+/ALK3+/CAII− cells, which map chiefly in cluster 1, as the expression of PDX1 (the marker for which P2RY1 is a surface
surrogate; green) and that of CAII (red) are mutually exclusive. (B) Experimental outline for the transplantation of FACS-sorted P2RY1+/ALK3bright+ cells under
the kidney capsule of immunodeficient nu/nu mice. (C) Circulating peripheral hC-pep measured at day 0 and weeks 2 and 4. (D) Circulating peripheral hC-pep
measured during an IPGTT at 0 min and 60 min after glucose challenge. Each of the first three charts in C and D represents an individual experiment, with the
sex of the recipient mice indicated on top. The fourth chart, in a larger size, is the combination of all of the experiments. *P < 0.05, **P < 0.01, ***P < 0.001.
Error bars: SD. (E, Left) Quantification of the percentage of endocrine (INS, GCG, SST), acinar (AMY), and ductal (CK19) DAPI+ cells in the grafts of n = 3
transplanted, THR-123–treated animals. Only transplanted pancreatic cells (defined as expressing any of the above markers plus DAPI) were counted in the
graft region, and values represent percentages vs. the total counted cells. (Right) Relative estimated percentages of engrafted cells according to their general
lineage (endocrine, acinar, ductal). Error bars: SD. (F) Representative confocal immunofluorescence imaging of z-stack maximal projections showing ex-
pression of select markers of the grafted cells in the kidney subcapsular space of recipient mice. (i) Example of disorganized acinar (AMY, green) and ductal
(CAII, red) tissue. (Scale bar, 100 μm.) (ii) Example of well-organized engrafted tissue showing fully formed acini (AMY, green), typical pancreatic epithelial
architecture (E-cadherin, ECAD, red), and a small cluster of INS-producing cells (INS, gray). Details are shown in (iii). [Scale bars, 100 μm in (ii) and 50 μm in (iii).]
(iv) Primitive ductal structures are shown in magenta (E-CAD, red + cytokeratin 19, CK19, white). (Scale bar, 25 μm.) (v) Endocrine clusters surrounded by ductal
structures: Chromogranin A (CHGA, green); PDX1 (red); CK19, gray; and DAPI (blue). (Scale bar, 50 μm.) (vi) Example of endocrine cluster showing multiple
single-hormone expressing cells: GCG (green); INS (red), SST (gray); and DAPI (blue). (Scale bar, 25 μm.) Merged images are depicted following those of single
channels (n = 3 biological replicates with 6 mice per group).





























INS-secreting cells from the engrafted P2RY1+/ALK3bright+
cells. Average basal hC-pep in plasma at 4 wk was ∼0.1 ng/mL.
This figure is in line with hC-pep values reported at any time
point prior to week 8 postprocedure when human embryonic
stem cell-derived stage 4 undifferentiated progenitors are
transplanted (58), despite a 10× lower cell dosage per mouse. Of
note, the concentration of hC-pep in blood was higher in the
THR-123 group than in saline-injected mice (P < 0.05 at week 2
and P < 0.001 at week 4). An intraperitoneal glucose tolerance
test (IPGTT) conducted at day 15 revealed that engrafted cells in
both groups release INS in response to glucose stimulation
(Fig. 5D), further supporting that INS-expressing cells are
functional neogenic β-like cells. Again, while this was observed in
both groups, responses were significantly stronger in those ani-
mals treated with THR-123. No statistically significant differ-
ences were observed between males and females. All animals
were killed at day 16, and immunofluorescence of the grafts was
performed. The quantification of the percentage of endocrine
(INS+, GCG+, SST+), acinar (AMY+), and ductal (CK19+)
cells was done by sampling transplanted kidney sections of n =
3 THR-123–treated (Fig. 5E, red columns) and n = 3 saline-
treated (Fig. 5E, black columns) mice and counting pancreatic
cells within the graft by FIJI/ImageJ (Fig. 5E). We observed a
2.7-fold reduction in the overall number of engrafted cells in
sampled sections of controls vs. THR-123–treated mice (P =
0.025). In particular, there was a 2.5-fold (P = 0.08, not signifi-
cant, n.s.) increase in the number of INS+ cells detected in the
THR-123 group vs. controls. These observations are aligned with
our previous determination that BMP-7 increased the mitotic
rate of sorted ALK3bright+/P2RY1+ cells in vitro by ∼2.5-fold (4).
However, there were no statistical differences between both
groups in terms of relative percentages of specific cell types
(excluding SST-expressing cells, undetected in controls). There-
fore, differences in circulating C-peptide are not due to differ-
entiation biases, but probably only reflect a differential
expansion of the transplanted undifferentiated cells when ani-
mals were treated with THR-123 or saline. Of note, these values
represent only estimations based on the sampling of a small
number of animals.
Fig. 5F shows representative images of pancreatic cell types in
the grafts of THR-123–treated mice. Acinar tissue was detected
in discrete regions either in a disorganized fashion, intermingled
with ductal cells (Fig. 5 F, i), or in well-developed acinar struc-
tures (shown in Fig. 5 F, ii with an endocrine cluster) with typical
epithelial morphology (Fig. 5 F, iii) and small ductules (Fig. 5 F,
iv). Although CK19 is a marker already found in the sorted
fraction (KRT19) (Fig. 1D), the fact that we observed CAII+
cells when P2RY1+/ALK3bright+ cells are nearly 100% CAII− (4)
(Fig. 5A and SI Appendix, Fig. S6 A–F) suggests that they have
arisen by differentiation. AMY+ cells may have also differenti-
ated along the ducto-acinar axis. Our data do not offer evidence
of draining into ducts, and we cannot discard some autodiges-
tion. However, pancreatic amylase is allosterically activated by
chloride in the duodenum (59, 60). Other pancreatic enzymes
also require the duodenum/intestinal mucosa microenvironment
(absent in grafts) for activation. Therefore, we speculate that
zymogen activation levels in the graft may be insufficient for
extensive autodigestion.
Endocrine clusters were small (8 to 15 cells) and contained
monohormonal cells expressing either INS, GCG, or SST
(Fig. 5 F, v and vi). Considering that the transplanted populations
are devoid of endocrine cells (4) (Figs. 1D and 4A and SI Ap-
pendix, Fig. S5C) and that the circulating hC-pep levels increase
with time (Fig. 5C), we hypothesize that these clusters also arise by
differentiation. Of note, while we did not transplant the negative
fraction as a negative control, our previous experiments strongly
suggest that it is strongly depleted in mature pancreatic markers,
and completely devoid of progenitor-like cells (4). In summary,
sorted progenitor-like cells transplanted into immunodeficient
animals differentiate along all pancreatic lineages.
PDX1+/ALK3+/CAII− Progenitor-like Cells Exist in Pancreata of T1D/T2D
Donors Regardless of the Duration of the Disease. If progenitor-like
cells were unaffected by T1D autoimmunity, such discovery may
open the door to therapies aimed at their in situ activation for
regenerative purposes. We have determined that the P2RY1+/
ALK3bright+ fraction is highly enriched in cells with a PDX1+/
ALK3+/CAII− phenotype (4) (SI Appendix, Fig. S6 A–F), which
Fig. 6. PDX1+/ALK3+/CAII− cells are present in the
large ducts of T1D/T2D donors. (A) Representative
confocal immunofluorescence imaging of a z-stack
maximal projection showing expression of ALK3
(red), CAII (green), PDX1 (gray), and DAPI (blue) from
human donors. (Left) Nondiabetic (Upper) and short-
term T1D (Lower). (Right) Medium-term (Upper) and
long-term (Lower) T1D. White arrowheads indicate
cells with a PDX1+/ALK3+/CAII− phenotype. (B) Quanti-
fication of PDX1+/ALK3+/CAII− cells calculated as a per-
centage of overall PDX1+/ALK3+ ductal cells in large
human pancreatic ducts across the head, body, and tail
of the pancreas, for control, short-term, medium-term,
and long-term diabetic donors. Error bars: SE. No sta-
tistically significant differences were detected between
groups. (C) Representative confocal immunofluores-
cence imaging of a z-stack maximal projection showing
the presence of PDX1+/ALK3+/CAII− cells in a T2D donor.
(Scale bars, 200 μm for low-magnification and 50 μm
for high-magnification images.)






















is quantifiable by immunofluorescence in human samples. To
determine if such cells are present in ducts after disease onset,
we examined the expression of PDX1, ALK3, and CAII in short-
(0 to 5 y), medium- (6 to 10 y), and long- (>10 y) term T1D
donor samples. Nondiabetic controls were used for comparison;
n = 3 donors per group, plus one T2D donor, were selected for
analysis (demographics in SI Appendix, Table S1). For each do-
nor, three histological sections containing MPDs (characterized
by a fibromuscular layer) were used for each of the three ana-
tomical regions of the pancreas (head, body, and tail).
Immunofluorescence of PDX1 in paraffin-embedded nPOD
(Network for Pancreatic Organ Donors with Diabetes) pancre-
atic samples is challenging and has not been reported thus far.
Therefore, we optimized the protocol using control and T1D
sections that encompassed both islets and ducts in the same field.
We found that PDX1 signal was very abundant not only in islets
(as expected), but also throughout the entirety of the ductal tree
(Fig. 6 A and C and SI Appendix, Fig. S6G). SI Appendix, Fig.
S6G shows gradual loss of INS, PDX1, and P2RY1 in islets as
T1D progresses. However, PDX1 signal remains strong in ductal
structures regardless of the stage of the disease. This protocol is
described in SI Appendix.
We also detected nuclear PDX1 in mature ductal cells that
also expressed CAII (Fig. 6 A and C). While scRNA-seq in-
dicated that PDX1 expression is restricted to a small proportion
of ALK3+/CAII− cells, predominantly within cluster 1, this
analysis was done on sorted ALK3bright+ cells, which represent
only a fraction of all ALK3+ cells in the ductal tree. In fact, this
analysis confirmed our previous observation (4) that PDX1+/
CAII+ are generally ALK3dim+, whereas PDX1+/CAII− cells are
invariably ALK3bright+ (Fig. 6A). This also explains why the
ALK3bright+/P2RY1+ sorting conducted for transplantation re-
sults in the depletion of most CAII+ cells (4) (Fig. 5A and SI
Appendix, Fig. S6 A–F).
PDX1+/ALK3+/CAII− ductal cells, often in an intercalated
pattern with PDX1+/ALK3+/CAII+ cells, were detected in head,
body, and tail of all donors, regardless of the duration of the
disease (Fig. 6A). The percentage of PDX1+/ALK3+ cells vs.
DAPI, and that of CAII− and CAII+ cells within PDX1+/
ALK3+ cells, was calculated by FIJI/ImageJ for the epithelial
lining of all of the major ducts found in each section (Fig. 6B).
The overall percentage of PDX1+/ALK3+/CAII− cells ranged
between 5% and 12% of all PDX1+/ALK3+ ductal cells exam-
ined (the remaining being CAII+). There were no statistically
significant differences between control, short-, medium-, or long-
term samples. No meaningful differences were observed either
when comparing the different regions of the pancreas within
each donor. These cells were also detected in a sample from a
T2D donor (Fig. 6C), but no quantification was attempted.
Taken together, these results indicate that cells with a
progenitor-like immunofluorescence signature (PDX1+/ALK3+/
CAII−) exist in the ductal tree of T1D patients regardless of the
duration of the disease. It remains to be established whether
these cells exhibit the same multipotency previously established
for nondiabetic donors.
Discussion
We present the high-resolution characterization of a human
pancreatic ductal progenitor cell niche. All previous analyses of
the human pancreas by scRNA-seq have been performed on
isolated islets (53–56, 61), which contain remnants of the acini
and ducts. However, the number of sequenced ductal cells was
invariably low, and probably depleted of the major ductal cells
that are the subject of our study. Furthermore, the ductal identity
of any given cell was determined indirectly by bioinformatics a
posteriori. Our study design circumvents these limitations by
focusing on a specific lineage of the pancreas and prevalidating
its identity by cell sorting.
scRNA-seq of a sorted ductal population previously shown to
harbor cells with progenitor-like characteristics (4) revealed an
unexpected degree of heterogeneity, with cells spanning a broad
range of differentiation stages across two major axes, one
encompassing mature ductal cell types and the other showing
progressive acinarity. The existence of a gradient of expression of
acinar genes in clusters 5 and 6 rules out the possibility of am-
bient contamination of acinar RNA during the procedure (which
would be equally detected in all clusters), and suggests an active
transition between the cells of these clusters. Acinar-to-ductal
metaplasia is a phenomenon by which, in response to inflammation
or stress, acinar cells de-differentiate into progenitor-like
(metaplastic) ductal cells. Such cells are then endowed with
the capacity to regenerate the damaged organ (62–64). This
process only becomes irreversible when cells acquire oncogenic
Krasmutations or are subjected to persistent/aberrant signaling,
which prevent redifferentiation and initiate further progression
into pancreatic adenocarcinoma (65). We believe that the
ducto-acinar ALK3bright+ axis described herein represents cells
in the process of transitioning between these two lineages,
which suggests that this reversible transdifferentiation may be
more common than previously thought. Consistent with this
hypothesis is the observation that GP2, an acinar-to-ductal
transitional marker (49), is almost exclusively detected in the
ducto-acinar clusters 5 and 6 (Fig. 3D).
Cluster 1 cells displayed strong inflammation/stress responses.
While dissociation and sorting may induce stress, it is doubtful
that this is the reason behind our observation. If that were the
case, we would also probably observe it in the other clusters,
which have also undergone the same process. Stress in the
pancreatic microenvironment is a well-studied phenomenon.
The exocrine pancreas is the organ with the highest protein
synthesis, producing liters of pancreatic juices daily. Leaving
aside the potential risk of intracellular activation of digestive
enzymes (the main cause of pancreatitis), protein synthesis itself
is a key stressor of the exocrine pancreas at all times (66). Stress
has been associated with de-differentiation and acquisition of
progenitor-like characteristics in ducts (67–69), but whether the
stress signature of cells in cluster 1 is linked to de-differentiation
is merely presented as a hypothesis.
This cluster also had the highest levels of PDX1 and ID1-2,
and -4, known housekeepers of progenitor-like phenotypes (4,
17). Of note, while P2RY1+ cells were also found throughout the
dataset, their scarcity made it difficult to analyze them. This is
because P2RY1 expression is very low. As shown in SI Appendix,
Fig. S6F, the relative level of expression (2−ΔCt) of P2RY1 was
5-fold lower than that of PDX1 and 60-fold lower than that of
KRT19. Our findings are confirmed by the entry for pancreas in
the Human Protein Atlas, which shows an average of transcripts
per million across 248 samples to be 0.8 (i.e., there is a proba-
bility of finding 0.8 transcripts of P2RY1 per one million reads).
As reference, PDX1 has 6.2 and INS has 3535.7. As recently
reviewed in ref. 70, scRNA-seq cannot be used to draw mean-
ingful conclusions from low-expressing genes.
Interestingly, albeit relatively widespread throughout all
ALK3bright+ clusters, the expression of the progenitor marker
CTNND1 (p120ctn) was highest in cluster 1. During develop-
ment, cells with high p120ctn expression define “trunk” (major)
ductal populations that give rise to both ducts and endocrine
cells, whereas p120ctnlow cells, typically located in the tip of the
ducts, only differentiate into acini (44). Similarly, cluster 1 had
the highest expression of CEACAM6, which was independently
predicted to be a progenitor marker in the pancreas (47); as well
as PROM1, a marker of tripotent colony-forming progenitor cells
in the adult murine pancreas (48). Enrichment in progenitor-like
cells from cluster 1 was predicted to occur by P2RY1+/ALK3bright+
sorting, since P2RY1 (PDX1) selection mostly excludes the non-
progenitor CAII+ fraction therefrom.





























We did not expect to detect ductal-to-endocrine transitional
cells in our dataset due to the very design of the experiment,
where endocrine cells (ALK3−) are specifically excluded by
gating on the ALK3bright+ fraction. Our study is based on a static
snapshot of the pancreas, and therefore conclusions about potential
transitions are necessarily speculative and based on bioinformatics
predictions. Even so, the integration with the whole-pancreas
datasets, and especially the pseudotemporal arrangement analysis,
strongly suggests the existence of a ducto-endocrine axis. In this
particular setting, where none of the donors had diabetes and
sources of stress appear to be largely physiological, it is plausible
that there may be a basal level of endocrine cell formation from de-
differentiated ductal cells, even if the full activation of ductal-
mediated regenerative mechanisms may require more extensive
damage (3, 71).
Transplantation is stressful for dissociated pancreatic epithe-
lial cells (4). In this context, we further hypothesized that xen-
otransplanting sorted P2RY1+/ALK3bright+cells may offer us a
glimpse of their potency under stress in vivo. We show here that
these cells, which are hormone-negative at the time of trans-
plantation, can differentiate into monohormonal GCG-, SST-,
and INS-expressing cells, as well as cells of the acinar and ductal
lineages. While some regions of the graft did not exhibit mature
histological patterns, the organization of other regions in acini,
small endocrine clusters, and ductules was remarkable, consid-
ering that only single cells sorted for ALK3 and P2RY1 (none of
which is expressed in human acinar tissue) were transplanted. Our
ultimate goal is not transplantation, but rather the activation of
progenitor cells in situ. As indicated earlier, these experiments
were only designed to establish proof-of-concept of in vivo mul-
tilineage differentiation, and not to revert diabetes in a disease
model. Therefore, we did not conduct any comparison with islets
or extensive functional studies. Still, we show that engrafted INS+
cells secreted INS in response to glucose stimulation in vivo, which
is the hallmark of functional β-like cells. This process was en-
hanced when the animals were treated systemically with THR-123,
an ALK3 receptor agonist (57). This finding, coupled with our
discovery that PDX1+/ALK3+/CAII− cells (a marker combination
signature equivalent to P2RY1+/ALK3bright+) (4) are present in
T1D/T2D donors, suggests potential therapeutic avenues to in-
duce β-cell regeneration in situ. To determine if that is a possi-
bility, future studies will explore whether cells sorted from T1D/
T2D donors also exhibit multipotency.
The existence of progenitor cells with the capacity to re-
generate the endocrine and exocrine compartments in the adult
human pancreas remains a contentious issue. However, the re-
cent emergence of high-resolution analytical tools is bringing
much needed nuance to the debate. Lineage barriers are now
blurrier than ever, a discovery that calls into question the validity
of many earlier lineage-tracing conclusions. The high degree of
developmental heterogeneity supports the dynamic fate plasticity
and the constant state of flux of the ductal compartment. If
harnessed, these findings could be the basis for the development
of pharmacological therapies for endocrine regeneration.
Materials and Methods
Human pancreata were processed as detailed in the SI Appendix. Methods
for FACS of cells for scRNA-seq analysis and transplantation are also ex-
panded therein. Animal experiments were conducted under the oversight of
the University of Miami Institutional Animal Care and Use Committee. Pro-
cedures for transplantation and metabolic analyses of in vivo differentiation
as well as immunofluorescence analyses are detailed in the SI Appendix.
Single-cell capture, library preparation, and sequencing were performed at
Genewiz (South Plainfield, NJ). Details on library preparation, computational
analyses, and statistics are provided in SI Appendix.
Data Availability. Sequencing data have been deposited in the Gene Ex-
pression Omnibus (GEO), accession no. GSE131886. Previously published scRNA-
seq data reanalyzed here are available at under GEO accession nos. GSE81076/
GSE85241. Source data for figures are provided in the SI Appendix reagent
table. Code/Rscript files for the analyses reported are available in the GitHub
repository https://github.com/JDBLab/Pancreas_ductal_scRNAseq (72).
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